Sandra BERNDT
12Patents
4h-index
48Co-inventors
52Inventor score
Filing activity: Dec 10, 2014 → Apr 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10022453B2 | Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) | Chemistry; Metallurgy | 14 | Active |
| US10485880B2 | Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies | Human Necessities | 11 | Active |
| US11123439B2 | Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups | Human Necessities | 5 | Active |
| US11478554B2 | Antibody drug conjugates (ADCS) having enzymatically cleavable groups | Human Necessities | 4 | Active |
| US11071788B2 | Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies | Human Necessities | 4 | Active |
| US11685714B2 | Prodrugs of cytotoxic active agents having enzymatically cleavable groups | Chemistry; Metallurgy | 2 | Active |
| US11660351B2 | Antibody drug conjugates (ADCs) having enzymatically cleavable groups | Chemistry; Metallurgy | 2 | Active |
| US11433140B2 | Specific antibody drug conjugates (ADCs) having KSP inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11427640B1 | CCR8 antibodies for therapeutic applications | Physics | 0 | Active |
| US12144865B2 | Antibody drug conjugates with enzymatically cleavable groups | Human Necessities | 0 | Active |
| US12065497B2 | Methods of treatment using CCR8 antibodies | Physics | 0 | Active |
| US11427578B1 | Substituted pyrrolopyridine-derivatives | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.